20D7SL CAR’s cross-reactivity against human and murine TYRP1 allows us to evaluate toxicity in the syngeneic B16 melanoma model in immunocompetent C57BL/6 mice subjected to lymphodepleting total body irradiation one day prior to CAR-T cell administration. The gene discussed is TYRP1; the disease is melanoma.